EUROPE CLINICAL NUTRITION MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • EUROPE CLINICAL NUTRITION MARKET FORECAST 2019-2028

EUROPE CLINICAL NUTRITION MARKET FORECAST 2019-2028

The Europe clinical nutrition market is estimated to grow with a CAGR of 4.63%, during the forecast years of 2019 to 2028. Significant developments in healthcare infrastructure, the surge in chronic disorders, and the availability of nutrition in the region, drive the market growth. The Europe clinical nutrition market growth is analyzed across the United Kingdom, Russia, Italy, Poland, Germany, Belgium, France, and the rest of Europe.

EUROPE CLINICAL NUTRITION MARKET FORECAST 2019-2028

Europe Clinical Nutrition Market by Route of Administration (Oral, Enteral, Parenteral) by Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, Other Applications) by End-user (Pediatric, Geriatric, Adults) and by Geography.

Request free sample

The Europe clinical nutrition market is estimated to grow with a CAGR of 4.63%, during the forecast years of 2019 to 2028. Significant developments in healthcare infrastructure, the surge in chronic disorders, and the availability of nutrition in the region, drive the market growth.
europe clinical nutrition market

To know more about this report, request a free sample copy

The Europe clinical nutrition market growth is analyzed across the United Kingdom, Russia, Italy, Poland, Germany, Belgium, France, and the rest of Europe. Clinical nutrition in the United Kingdom is termed as Food for Special Medical Purposes (FSMP). They are characterized by special food products intended to meet the dietary and nutritional requirements of patients living with a disorder, disease, or medical condition. FSMPs also caters to individuals who are unable to permanently and temporarily receive adequate nutritional consumption, either from normal food items or by customizing their normal diet.

FSMPs are also required by patients with food tolerances, inherited metabolic diseases, and chronic illnesses. Such disorders include, cystic fibrosis, chronic obstructive pulmonary disease (COPD), kidney failure, lung, heart, and muscular system diseases, psychiatric and neurological conditions, and malnutrition. Malnourished patients also use clinical nutrition products, and the condition impacts nearly three million people in the United Kingdom. As a result, the social and health expenditure for malnutrition is valued at over $24 billion, in England, annually.

BASF SE, headquartered in Germany, is one of the largest chemical enterprises globally, and its product portfolio comprises, performance products, chemicals, functional material and solutions, oil and gas, and agricultural solutions. The company functions in Europe, the Americas, Africa, and the Middle East, and the Asia Pacific. In June 2020, BASF and GACNE extended their partnership to implement digital automotive coatings solutions in China.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • INCREASING PREVALENCE OF CHRONIC DISEASES AND LIFESTYLE ASSOCIATED DISEASE
      • RISE IN ELDERLY POPULATION
      • HIGH OCCURRENCE OF MALNUTRITION AMONG HOSPITALIZED PATIENTS
    •    KEY RESTRAINTS
      • LACK OF AWARENESS FOR CLINICAL NUTRITION
      • COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
      • STRINGENT REGULATIONS
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • ENTERAL
    • PARENTERAL
  3. MARKET BY APPLICATION
    • CANCER
    • NEUROLOGICAL DISEASES
    • GASTROINTESTINAL DISORDERS
    • METABOLIC DISORDERS
    • OTHER APPLICATIONS
  4. MARKET BY END-USER
    • PEDIATRIC
    • GERIATRIC
    • ADULTS
  5. GEOGRAPHICAL ANALYSIS
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. COMPANY PROFILES
    • ABBOTT LABORATORIES
    • AMERICAN REGENT INC
    • BASF SE
    • BAXTER INTERNATIONAL INC
    • B BRAUN
    • DANONE
    • EXELA PHARMA SCIENCES
    • GRIFOLS SA
    • LONZA LTD
    • MEIJI HOLDINGS CO LTD
    • NESTLE HEALTH SCIENCE
    • OTSUKA HOLDINGS CO LTD
    • RECKITT BENCKISER GROUP PLC
    • SANOFI
    • SICHUAN KELUN PHARMACEUTICAL CO LTD

TABLE LIST

TABLE 1: MARKET SNAPSHOT – CLINICAL NUTRITION

TABLE 2: EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 4: EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: EUROPE CLINICAL NUTRITION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: EUROPE CLINICAL NUTRITION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 8: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

FIGURES LIST

FIGURE 1: MAJOR CATEGORIES OF EUROPE HEALTH SPENDING, 2017

FIGURE 2: COMPLICATIONS OF ENTERAL FEEDING

FIGURE 3: PORTER’S FIVE FORCE ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: KEY INVESTMENT INSIGHTS

FIGURE 7: EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, IN 2019

FIGURE 8: EUROPE CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)

FIGURE 9: EUROPE CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)

FIGURE 10: EUROPE CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)

FIGURE 11: EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, IN 2019

FIGURE 12: EUROPE CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)

FIGURE 13: EUROPE CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)

FIGURE 14: EUROPE CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)

FIGURE 15: EUROPE CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)

FIGURE 16: EUROPE CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)

FIGURE 17: EUROPE CLINICAL NUTRITION MARKET, BY END-USER, IN 2019

FIGURE 18: EUROPE CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)

FIGURE 19: EUROPE CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)

FIGURE 20: EUROPE CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)

FIGURE 21: EUROPE CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 22: GERMANY CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 23: FRANCE CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 24: THE UNITED KINGDOM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 25: ITALY CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 26: RUSSIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 27: BELGIUM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 28: POLAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 29: REST OF EUROPE CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • ENTERAL
    • PARENTERAL
  2. MARKET BY APPLICATION
    • CANCER
    • NEUROLOGICAL DISEASES
    • GASTROINTESTINAL DISORDERS
    • METABOLIC DISORDERS
    • OTHER APPLICATIONS
  3. MARKET BY END-USER
    • PEDIATRIC
    • GERIATRIC
    • ADULTS

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now